Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
15.87
-0.45 (-2.76%)
At close: Mar 3, 2026, 4:00 PM EST
15.96
+0.09 (0.54%)
After-hours: Mar 3, 2026, 7:58 PM EST

Sarepta Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-713.41235.24-535.98-703.49-418.78
Depreciation & Amortization
44.5237.7244.441.8638.02
Loss (Gain) From Sale of Assets
---102--102
Loss (Gain) From Sale of Investments
12-40.28-15.86-8.084.39
Stock-Based Compensation
123.4184.3182.51233.02113.94
Other Operating Activities
249.9793.83407.02150.8119.43
Change in Accounts Receivable
203.76-201.66-185.7-61.64-51.65
Change in Inventory
-301.09-395.17-147.71-50.78-83.77
Change in Accounts Payable
104.27110.65-50.14147.5723.3
Change in Unearned Revenue
72.05-32.16-86.83-89.24-89.24
Change in Other Net Operating Assets
-0.94-198.26-10.7114.62103.2
Operating Cash Flow
-205.48-205.79-500.99-325.35-443.17
Capital Expenditures
-101.97-136.96-76.11-30.82-38.49
Sale (Purchase) of Intangibles
-7.88-1090.76-1.4399.69
Investment in Securities
179.49902.52-180.46-1,015434.21
Investing Cash Flow
69.64755.56-165.8-1,047495.41
Long-Term Debt Issued
---1,127-
Long-Term Debt Repaid
-162.59-0.07--823.23-
Net Debt Issued (Repaid)
-162.59-0.07-304.17-
Issuance of Common Stock
38.779.5351.2530.04569.33
Repurchase of Common Stock
-25.01----7.77
Other Financing Activities
-19.4545.3573.76-101.7-
Financing Cash Flow
-168.34124.81125232.51561.57
Net Cash Flow
-304.18674.58-541.79-1,140613.81
Free Cash Flow
-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Margin
-13.99%-18.02%-46.41%-38.17%-68.62%
Free Cash Flow Per Share
-3.07-3.18-6.25-4.07-5.93
Cash Interest Paid
14.9115.8615.9244.4255.95
Cash Income Tax Paid
37.6322.5915.081.70.58
Levered Free Cash Flow
95.92-432.21-330.11-54.65-8.7
Unlevered Free Cash Flow
119.75-420.71-316.36-21.3731.01
Change in Working Capital
78.04-716.61-481.09-39.47-98.17
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q